Kronos Worldwide, Inc. produces and markets titanium dioxide pigments (TiO2) in Europe, North America, the Asia Pacific, and internationally. The company produces TiO2 in two crystalline forms, rutile and anatase to impart whiteness, brightness, opacity, and durability for various products, including paints, coatings, plastics, paper, fibers, and ceramics, as well as for various specialty products, such as inks, foods, and cosmetics and pharmaceuticals. It also produces ilmenite, a raw material used directly as a feedstock by sulfate-process TiO2 plants; iron-based chemicals, which are used as treatment and conditioning agents for industrial effluents and municipal wastewater, as well as in the manufacture of iron pigments, cement, and agricultural products; specialty chemicals for use in the formulation of pearlescent pigments, and production of electroceramic capacitors for cell phones and other electronic devices, as well as for use in natural gas pipe, and other specialty applications. In addition, the company provides technical services for its products. It sells its products under the KRONOS brand through agents and distributors to paint, plastics, decorative laminate, and paper manufacturers. The company was founded in 1916 and is headquartered in Dallas, Texas. Kronos Worldwide, Inc. is a subsidiary of Valhi, Inc.

Kronos Worldwide Inc

An update from Keros Therapeutics ( ($KROS) ) is now available. On January 9, 2026, Keros Therapeutics updated its corporate presentation for inves...

Keros Therapeutics Highlights Rinvatercept Strategy in Updated Presentation

Bank of America Securities analyst Jason Zemansky maintained a Hold rating on Keros Therapeutics today and set a price target of $20.00. According ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	KRO	$5.47	+4.19%	367.60K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	KRO	$5.47	+4.2%	367.60K
3
4
5
6

KRO

KRO

Get Kronos Worldwide Inc Data in Excel

Get Kronos Worldwide Inc Data in Excel